Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
Location: Canada
Total raised: $4.9M
Investors 3
| Date | Name | Website |
| 05.07.2024 | Pax Moment... | paxmv.com |
| - | Pax Moment... | paxmv.vc |
| 30.11.2024 | Swan Ventu... | swanventur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.04.2026 | Seed | $4.9M | Debiopharm |
Mentions in press and media 8
| Date | Title | Description |
| 23.04.2026 | ViewsML: $4.9 Million Seed Funding Raised To Commercialize AI-Powered Virtual Biomarker Staining Platform | ViewsML announced it has raised $4.9 million in an oversubscribed seed funding round to accelerate commercialization of its virtual biomarker staining platform. The round was led by Wittington Ventures, with participation from Continuum Hea... |
| 21.04.2026 | ViewsML Secures $4.9M for AI Biomarker Revolution | ViewsML secured $4.9M in seed funding. This fuels its AI-driven virtual biomarker platform. The technology extracts critical per-cell insights directly from standard H&E pathology images. It eliminates traditional immunohistochemistry. ... |
| 21.04.2026 | ViewsML Raises $4.9M for AI-Driven Virtual Biomarker Staining Platform | What You Should Know The Funding: ViewsML, a company building the computational layer for biomarker discovery, has closed an oversubscribed $4.9M seed round led by Wittington Ventures, with significant strategic participation from Mayo Clin... |
| 20.04.2026 | ViewsML Raises $4.9M in Seed Funding | ViewsML, a Vancouver, BC, Canada-based biomarker discovery company, raised $4.9M in seed funding. The round was led by Wittington Ventures with participation from Continuum Health Ventures, Mayo Clinic, RiSC Capital, Debiopharm, WUTIF, Defi... |
| 18.08.2025 | ViewsML and iProcess Announce Strategic Partnership to Accelerate Delivery of AI-Powered Virtual Biomarker Testing | ViewsML Technologies iProcess Global Research Partnership brings ViewsML’s virtual IHC platform to iProcess customers - enabling faster, tissue-sparing biomarker testing We’re excited to partner with iProcess to bring the benefits of our vi... |
| 17.06.2025 | ViewsML and Debiopharm Collaborate to Advance Virtual Biomarker Technology in Drug Research | ViewsML Technologies Debiopharm Debiopharm taps ViewsML’s AI-driven platform to streamline biomarker detection in oncology research. Working with ViewsML allows us to integrate advanced AI solutions into our biomarker research, optimizing o... |
| 08.04.2025 | ViewsML and Dartmouth Health Partner to Advance AI-Driven Virtual Biomarkers and Diagnostics | ViewsML Technologies Dartmouth Hitchcock Medical Center ViewsML's AI technology joins Dartmouth Health's clinical expertise to create virtual biomarkers that transform pathology diagnostics ViewsML's transformative AI platform represents a ... |
| - | ViewsML | “Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.” |